DavisPB, DrummML, KonstanMW. State of the art: Cystic fibrosis. Am J Respir Crit Care Med, 1996; 154:1229–1256.
3.
CoreyM, FarewellV. Determinants of mortality from cystic fibrosis in Canada, 1970–1989. Am J Epidemiol, 1996; 143:1007–1017.
4.
RosenfeldM, DavisR, FitzSimmonsS, PepeM, RamseyB. Gender gap in cystic fibrosis mortality. Am J Epidemiol, 1997; 145:794–803.
5.
DodgeJA, LewisPA, StantonM, WilsherJ. Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J, 2007; 29:522–526.
6.
MacKenzieT, GiffordAH, SabadosaKA, et al.Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: Survival analysis of the Cystic Fibrosis Foundation Patient Registry. Ann Intern Med, 2014; 161:233–241.
7.
AlicandroG, FrovaL, Di FraiaG, ColomboC. Cystic fibrosis mortality trend in Italy from 1970 to 2011. J Cyst Fibros, 2014Aug20 [Epub ahead of print]; DOI: 10.1016/j.jcf.2014.07.010.
8.
StephensonAL, TomM, BerthiaumeY, et al.A contemporary survival analysis of individuals with cystic fibrosis: A cohort study. Eur Respir J, 2014Nov13 [Epub ahead of print]; DOI: 10.1183/09031936.00119714.
LiZ, KosorokMR, FarrellPM, et al.Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA, 2005; 293:581–588.
11.
Harness-BrumleyC, ElliottA, RosenbluthD, RaghavanD, JainR. Gender differences in outcomes of patients with cystic fibrosis. J Womens Health (Larchmt), 2014; 23;IN PRESS.
12.
SweezeyNB, RatjenF. The cystic fibrosis gender gap: Potential roles of estrogen. Pediatr Pulmonol, 2014; 49:309–317.
13.
JacksonAD, DalyL, JacksonAL, et al.Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: A birth cohort analysis. Thorax, 2011; 66:674–679.
14.
ChmielJF, AksamitTR, ChotirmallSH, et al.Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc, 2014; 11:1120–1129.
15.
ChmielJF, AksamitTR, ChotirmallSH, et al.Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi. Ann Am Thorac Soc, 2014; 11:1298–1306.
16.
ChotirmallSH, GreeneCM, OglesbyIK, et al.17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor. Am J Respir Crit Care Med, 2010; 182:62–72.
17.
ChotirmallSH, SmithSG, GunaratnamC, et al.Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis. N Engl J Med, 2012; 366:1978–1986.
18.
ChotirmallSH, GreeneCM, McElvaneyNG. Immune, inflammatory and infectious consequences of estrogen in women with cystic fibrosis. Expert Rev Respir Med, 2012; 6:573–575.
19.
CoakleyRD, SunH, ClunesLA, et al.17beta-estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. J Clin Invest, 2008; 118:4025–4035.
20.
JainR, RayJM, PanJH, BrodySL. Sex hormone-dependent regulation of cilia beat frequency in airway epithelium. Am J Respir Cell Mol Biol, 2012; 46:446–453.
